Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application

References

• Wiersinga WJ, Currie BJ, Peacock SJ. Melioidosis. The N Engl J Med 2012; 367:1035-44.
   PubMed Web of Science ®Google Scholar
• Currie BJ. Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment. Semin Respir Crit Care Med 2015; 36:111-25; PMID:25643275; https://doi.org/https://doi.org/10.1055/s-0034-1398389
   PubMed Web of Science ®Google Scholar
• Limmathurotsakul D, Funnell SG, Torres AG, Morici LA, Brett PJ, Dunachie S, Atkins T, Altmann DM, Bancroft G, Peacock SJ, Steering Group on Melioidosis Vaccine Development. Consensus on the development of vaccines against naturally acquired melioidosis. Emerg Infect Dis 2015; 21(6); PMID:25992835; https://doi.org/https://doi.org/10.3201/eid2106.141480
   PubMedGoogle Scholar
• Peacock SJ, Limmathurotsakul D, Lubell Y, Koh GC, White LJ, Day NP, Titball RW. Melioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposes. PLoS Negl Tropical Dis 2012; 6:e1488; PMID:22303489; https://doi.org/https://doi.org/10.1371/journal.pntd.0001488
   PubMed Web of Science ®Google Scholar
• Bondi SK, Goldberg JB. Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei. Expert Rev Vaccines 2008; 7:1357-65; PMID:18980539; https://doi.org/https://doi.org/10.1586/14760584.7.9.1357
   PubMed Web of Science ®Google Scholar
• Bennett B, Check IJ, Olsen MR, Hunter RL. A comparison of commercially available adjuvants for use in research. J Immunol Methods 1992; 153:31-40; PMID:1517600
   PubMed Web of Science ®Google Scholar
• Gurunathan S, Klinman DM, Seder RA. DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 2000; 18:927-74; PMID:10837079; https://doi.org/https://doi.org/10.1146/annurev.immunol.18.1.927
   PubMed Web of Science ®Google Scholar
• Wiersinga WJ, van der Poll T, White NJ, Day NP, Peacock SJ. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol 2006; 4:272-82; PMID:16541135; https://doi.org/https://doi.org/10.1038/nrmicro1385
   PubMed Web of Science ®Google Scholar
• Wiersinga WJ, Wieland CW, Dessing MC, Chantratita N, Cheng AC, Limmathurotsakul D, Chierakul W, Leendertse M, Florquin S, de Vos AF, et al. Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (Melioidosis). PLoS Med 2007; 4:e248; PMID:17676990; https://doi.org/https://doi.org/10.1371/journal.pmed.0040248
   PubMed Web of Science ®Google Scholar
• Chen YS, Hsiao YS, Lin HH, Yen CM, Chen SC, Chen YL. Immunogenicity and anti-Burkholderia pseudomallei activity in Balb/c mice immunized with plasmid DNA encoding flagellin. Vaccine 2006; 24:750-8; PMID:16169637; https://doi.org/https://doi.org/10.1016/j.vaccine.2005.08.069
   PubMed Web of Science ®Google Scholar
• Chen YS, Hsiao YS, Lin HH, Liu Y, Chen YL. CpG-modified plasmid DNA encoding flagellin improves immunogenicity and provides protection against Burkholderia pseudomallei infection in BALB/c mice. Infect Immunity 2006; 74:1699-705; PMID:16495541; https://doi.org/https://doi.org/10.1128/IAI.74.3.1699-1705.2006
   PubMed Web of Science ®Google Scholar
• van den Berg JH, Oosterhuis K, Schumacher TN, Haanen JB, Bins AD. Intradermal vaccination by DNA tattooing. Methods Mol Biol 2014; 1143:131-40; PMID:24715286; https://doi.org/https://doi.org/10.1007/978-1-4939-0410-5_9
   PubMedGoogle Scholar
• Wagemakers A, Mason LM, Oei A, de Wever B, van der Poll T, Bins AD, Hovius JW. Rapid outer-surface protein C DNA tattoo vaccination protects against Borrelia afzelii infection. Gene Ther 2014; 21:1051-7; PMID:25273355; https://doi.org/https://doi.org/10.1038/gt.2014.87
   PubMed Web of Science ®Google Scholar
• Bins AD, Jorritsma A, Wolkers MC, Hung CF, Wu TC, Schumacher TN, Haanen JB. A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression. Nat Med 2005; 11:899-904; PMID:15965482; https://doi.org/https://doi.org/10.1038/nm1264
   PubMed Web of Science ®Google Scholar
• van de Wall S, Walczak M, van Rooij N, Hoogeboom BN, Meijerhof T, Nijman HW, Daemen T. Tattoo delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7. Vaccines (Basel) 2015; 3:221-38; PMID:26343186; https://doi.org/https://doi.org/10.3390/vaccines3020221
   PubMed Web of Science ®Google Scholar
• Stary G, Olive A, Radovic-Moreno AF, Gondek D, Alvarez D, Basto PA, Perro M, Vrbanac VD, Tager AM, Shi J, et al. VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells. Science 2015; 348:aaa8205; PMID:26089520; https://doi.org/https://doi.org/10.1126/science.aaa8205
   PubMed Web of Science ®Google Scholar
• Ingolotti M, Kawalekar O, Shedlock DJ, Muthumani K, Weiner DB. DNA vaccines for targeting bacterial infections. Expert Rev Vaccines 2010; 9:747-63; PMID:20624048; https://doi.org/https://doi.org/10.1586/erv.10.57
   PubMed Web of Science ®Google Scholar
• Xu Y, Yuen PW, Lam JK. Intranasal DNA Vaccine for protection against respiratory infectious diseases: The delivery perspectives. Pharmaceutics 2014; 6:378-415; PMID:25014738; https://doi.org/https://doi.org/10.3390/pharmaceutics6030378
   PubMedGoogle Scholar
• Wegmann F, Gartlan KH, Harandi AM, Brinckmann SA, Coccia M, Hillson WR, Kok WL, Cole S, Ho LP, Lambe T, et al. Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens. Nat Biotechnol 2012; 30:883-8; PMID:22922673; https://doi.org/https://doi.org/10.1038/nbt.2344
   PubMed Web of Science ®Google Scholar
• Qin T, Yin Y, Huang L, Yu Q, Yang Q. H9N2 influenza whole inactivated virus combined with polyethyleneimine strongly enhances mucosal and systemic immunity after intranasal immunization in mice. Clin Vaccine Immunol 2015; 22:421-9; PMID:25673304; https://doi.org/https://doi.org/10.1128/CVI.00778-14
   PubMed Web of Science ®Google Scholar
• Torrieri-Dramard L, Lambrecht B, Ferreira HL, Van den Berg T, Klatzmann D, Bellier B. Intranasal DNA vaccination induces potent mucosal and systemic immune responses and cross-protective immunity against influenza viruses. Mol Ther 2011; 19:602-11; PMID:20959813; https://doi.org/https://doi.org/10.1038/mt.2010.222
   PubMed Web of Science ®Google Scholar
• Strieter RM, Belperio JA, Keane MP. Cytokines in innate host defense in the lung. J Clin Invest 2002; 109:699-705; PMID:11901175; https://doi.org/https://doi.org/10.1172/JCI15277
   PubMed Web of Science ®Google Scholar
• Kager LM, Weehuizen TA, Wiersinga WJ, Roelofs JJ, Meijers JC, Dondorp AM, van ′t Veer C, van der Poll T. Endogenous alpha2-antiplasmin is protective during severe gram-negative sepsis (melioidosis). Am J Resp Critical Care Med 2013; 188:967-75; PMID:23992406; https://doi.org/https://doi.org/10.1164/rccm.201307-1344OC
   PubMed Web of Science ®Google Scholar
• Weehuizen TA, Hommes TJ, Lankelma JM, de Jong HK, Roelofs JJ, de Vos AF, Colonna M, van der Poll T, Wiersinga WJ. Triggering receptor expressed on Myeloid Cells (TREM)-2 impairs host defense in experimental melioidosis. PLoS Negl Trop Dis 2016; 10:e0004747; PMID: 27253382; https://doi.org/https://doi.org/10.1371/journal.pntd.0004747
   PubMed Web of Science ®Google Scholar
• Conejero L, Potempa K, Graham CM, Spink N, Blankley S, Salguero FJ, Pankla-Sranujit R, Khaenam P, Banchereau JF, Pascual V, et al. The blood transcriptome of experimental melioidosis reflects disease severity and shows considerable similarity with the human disease. J Immunol 2015; 195:3248-61; PMID:26311902; https://doi.org/https://doi.org/10.4049/jimmunol.1500641
   PubMedGoogle Scholar
• Koh GC, Schreiber MF, Bautista R, Maude RR, Dunachie S, Limmathurotsakul D, Day NP, Dougan G, Peacock SJ. Host responses to melioidosis and tuberculosis are both dominated by interferon-mediated signaling. PloS One 2013; 8:e54961; PMID:23383015; https://doi.org/https://doi.org/10.1371/journal.pone.0054961
   PubMed Web of Science ®Google Scholar
• Weehuizen TA, Lankelma JM, De Jong HK, De Boer OJ, Roelofs JJ, Day NP, Gram H, De Vos AF, Wiersinga WJ. Therapeutic Administration of a Monoclonal Anti-Il-1beta antibody protects against experimental melioidosis. Shock 2016; 46(5):566-74; PMID:27219859; https://doi.org/https://doi.org/10.1097/SHK.0000000000000625
   PubMed Web of Science ®Google Scholar
• Easton A, Haque A, Chu K, Patel N, Lukaszewski RA, Krieg AM, Titball RW, Bancroft GJ. Combining vaccination and postexposure CpG therapy provides optimal protection against lethal sepsis in a biodefense model of human melioidosis. J Infect Dis 2011; 204:636-44; PMID:21791666; https://doi.org/https://doi.org/10.1093/infdis/jir301
   PubMed Web of Science ®Google Scholar
• Nelson M, Prior JL, Lever MS, Jones HE, Atkins TP, Titball RW. Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis. J Med Microbiol 2004; 53:1177-82; PMID:15585494; https://doi.org/https://doi.org/10.1099/jmm.0.45766-0
   PubMed Web of Science ®Google Scholar
• Sarkar-Tyson M, Smither SJ, Harding SV, Atkins TP, Titball RW. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders. Vaccine 2009; 27:4447-51; PMID:19490962; https://doi.org/https://doi.org/10.1016/j.vaccine.2009.05.040
   PubMed Web of Science ®Google Scholar
• Mott TM, Vijayakumar S, Sbrana E, Endsley JJ, Torres AG. Characterization of the Burkholderia mallei tonB mutant and its potential as a backbone strain for vaccine development. PLoS Negl Tropical Dis 2015; 9:e0003863; PMID:26114445; https://doi.org/https://doi.org/10.1371/journal.pntd.0003863
   PubMed Web of Science ®Google Scholar
• Aschenbroich SA, Lafontaine ER, Hogan RJ. Melioidosis and glanders modulation of the innate immune system: barriers to current and future vaccine approaches. Expert Rev Vaccines 2016; 15:1163-81; PMID:27010618; https://doi.org/https://doi.org/10.1586/14760584.2016.1170598
   PubMed Web of Science ®Google Scholar
• Cornell KA, Bouwer HG, Hinrichs DJ, Barry RA. Genetic immunization of mice against Listeria monocytogenes using plasmid DNA encoding listeriolysin O. J Immunol 1999; 163:322-9; PMID:10384131
   PubMed Web of Science ®Google Scholar
• Ferraz JC, Stavropoulos E, Yang M, Coade S, Espitia C, Lowrie DB, Colston MJ, Tascon RE. A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice. Infect Immunity 2004; 72:6945-50; PMID:15557616; https://doi.org/https://doi.org/10.1128/IAI.72.12.6945-6950.2004
   PubMed Web of Science ®Google Scholar
• Grote A, Hiller K, Scheer M, Munch R, Nortemann B, Hempel DC, Jahn D. JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res 2005; 33:W526-31; PMID:15980527; https://doi.org/https://doi.org/10.1093/nar/gki376
   PubMed Web of Science ®Google Scholar
• de Stoppelaar SF, van ′t Veer C, Claushuis TA, Albersen BJ, Roelofs JJ, van der Poll T. Thrombocytopenia impairs host defense in gram-negative pneumonia-derived sepsis in mice. Blood 2014; 124:3781-90; PMID:25301709; https://doi.org/https://doi.org/10.1182/blood-2014-05-573915
   PubMed Web of Science ®Google Scholar